281 related articles for article (PubMed ID: 24625566)
1. Homocysteine and risk of periprocedural myocardial infarction in patients undergoing coronary stenting.
Verdoia M; Schaffer A; Barbieri L; Cassetti E; Di Giovine G; Marino P; De Luca G;
J Cardiovasc Med (Hagerstown); 2015 Feb; 16(2):100-5. PubMed ID: 24625566
[TBL] [Abstract][Full Text] [Related]
2. MTHFR polymorphism and risk of periprocedural myocardial infarction after coronary stenting.
Verdoia M; Schaffer A; Cassetti E; Barbieri L; Di Giovine G; Marino P; De Luca G;
Nutr Metab Cardiovasc Dis; 2014 May; 24(5):532-7. PubMed ID: 24418373
[TBL] [Abstract][Full Text] [Related]
3. Platelet-larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization.
Verdoia M; Barbieri L; Schaffer A; Cassetti E; Marino P; Bellomo G; Sinigaglia F; De Luca G;
Heart Vessels; 2015 Jan; 30(1):20-7. PubMed ID: 24297745
[TBL] [Abstract][Full Text] [Related]
4. Effect of diabetes mellitus on periprocedural myocardial infarction in patients undergoing coronary stent implantation.
Verdoia M; Barbieri L; Schaffer A; Cassetti E; Di Giovine G; Nardin M; Bellomo G; Marino P; De Luca G;
Diabetes Metab Res Rev; 2015 Jan; 31(1):85-92. PubMed ID: 24898423
[TBL] [Abstract][Full Text] [Related]
5. Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty.
Verdoia M; Camaro C; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G
Atherosclerosis; 2013 May; 228(1):136-41. PubMed ID: 23518179
[TBL] [Abstract][Full Text] [Related]
6. Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
Verdoia M; Barbieri L; Schaffer A; Cassetti E; Di Giovine G; Bellomo G; Marino P; Sinigaglia F; De Luca G
J Thromb Thrombolysis; 2014 Apr; 37(3):345-52. PubMed ID: 23793523
[TBL] [Abstract][Full Text] [Related]
7. Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban.
Verdoia M; Pergolini P; Barbieri L; Rolla R; Nardin M; Negro F; Suryapranata H; De Luca G;
Thromb Res; 2018 Apr; 164():17-23. PubMed ID: 29475177
[TBL] [Abstract][Full Text] [Related]
8. Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI.
Verdoia M; Secco GG; Barbieri L; Cassetti E; Schaffer A; Sinigaglia F; Marino P; Suryapranata H; De Luca G;
Platelets; 2014; 25(5):367-72. PubMed ID: 24283589
[TBL] [Abstract][Full Text] [Related]
9. Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
Verdoia M; Schaffer A; Barbieri L; Di Giovine G; Marino P; De Luca G;
Diabetes Metab Res Rev; 2014 May; 30(4):297-304. PubMed ID: 24829966
[TBL] [Abstract][Full Text] [Related]
10. Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
Verdoia M; Schaffer A; Barbieri L; Sinigaglia F; Marino P; Suryapranata H; De Luca G;
Atherosclerosis; 2014 Sep; 236(1):169-74. PubMed ID: 25055060
[TBL] [Abstract][Full Text] [Related]
11. Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients.
Verdoia M; Schaffer A; Barbieri L; Di Giovine G; Marino P; Suryapranata H; De Luca G;
J Diabetes Complications; 2015; 29(4):517-22. PubMed ID: 25736187
[TBL] [Abstract][Full Text] [Related]
12. Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow).
Stone GW; Maehara A; Muller JE; Rizik DG; Shunk KA; Ben-Yehuda O; Genereux P; Dressler O; Parvataneni R; Madden S; Shah P; Brilakis ES; Kini AS;
JACC Cardiovasc Interv; 2015 Jun; 8(7):927-36. PubMed ID: 26003018
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
Verdoia M; Ceccon C; Nardin M; Suryapranata H; De Luca G;
Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):744-750. PubMed ID: 29656938
[TBL] [Abstract][Full Text] [Related]
14. Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention.
Negro F; Verdoia M; Nardin M; Suryapranata H; Kedhi E; Dudek D; De Luca G;
J Atheroscler Thromb; 2021 Feb; 28(2):137-145. PubMed ID: 33342966
[TBL] [Abstract][Full Text] [Related]
15. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
[TBL] [Abstract][Full Text] [Related]
17. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
Niccoli G; Sgueglia GA; Latib A; Crea F; Colombo A;
Catheter Cardiovasc Interv; 2014 Jan; 83(1):E37-44. PubMed ID: 23813627
[TBL] [Abstract][Full Text] [Related]
18. Impact of crossing technique on the incidence of periprocedural myocardial infarction during chronic total occlusion percutaneous coronary intervention.
Stetler J; Karatasakis A; Christakopoulos GE; Tarar MN; Amsavelu S; Patel K; Rangan BV; Roesle M; Resendes E; Grodin J; Abdullah S; Banerjee S; Brilakis ES
Catheter Cardiovasc Interv; 2016 Jul; 88(1):1-6. PubMed ID: 27014962
[TBL] [Abstract][Full Text] [Related]
19. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
[TBL] [Abstract][Full Text] [Related]
20. Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty.
Verdoia M; Secco GG; Cassetti E; Schaffer A; Barbieri L; Perrone-Filardi P; Marino P; Suryapranata H; Sinigaglia F; De Luca G
Blood Coagul Fibrinolysis; 2014 Mar; 25(2):107-13. PubMed ID: 24480844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]